documents: FDA-2014-D-0622-0002
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2014-D-0622-0002 | FDA | FDA-2014-D-0622 | Draft Guidance for Industry on Best Practices in Developing Proprietary Names for Drugs | Other | Guidance | 2014-05-29T04:00:00Z | 2014 | 5 | 2014-05-29T04:00:00Z | 2024-11-12T05:26:47Z | 1 | 0 | 090000648171c830 |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref